Please rotate your device to portrait mode

Who we are

Founded in 2011 by a group of science and industry experts, MaSTherCell provides unequalled quality manufacturing services to the cell therapy community.  Thanks to our customer-driven approach, our expertise in cell therapy and our location in the heart of Europe, we are ideally positioned for growth in this rapidly-evolving niche market.

The key competitive advantages that MaSTherCell offers to both its customers and its partners are:

  • A custom-made approach, tailored to the specific requirements of our clients, and designed to ensure short lead times and competitive costs in getting products to the market.
  • An in-house expertise that is drawn from both academic and industry backgrounds. Our highly flexible staff structure combines the ideal mix between scientific and market-oriented disciplines.
  • A complete range of services - our advanced Project Management Programme allows us to offer a centrally managed service that covers every step of the process 'from bench to market'.

Live our Values


At MaSTherCell we have cultural principles which are the foundations of our values.

Our principles are: Respect, Listening, Conviviality, the Human and the Quality.


Agility - Be the change

Cell therapy is a changing and dynamic sector that needs to adapt continuously. We therefore have a proactive, active and reactive attitude enabling us to respond in the right way to future trends and needs. Our open-minded and adaptable spirit allows us to be an agent of change. 

Engagement - Be part of our story

Engagement relies on the personal and daily investment of each employee in the company’s successful development. We encourage responsibility, autonomy and personal development for everyone. Our aim is for each person to be committed and enjoy being a member of the organisation.

Innovation - Breakthrough therapies

Innovation means continually seeking the most cutting-edge solutions and technologies. This quest leads us to put quality at the heart of our services in order to bring affordable therapies faster to patients.

Team Spirit - One team, one spirit

We draw our strength from our diversity and each person’s complementary skills.  As one team, we share a common vision to achieve our objectives. This mindset means that we support each other in our successes and failures. 

Transparency - The right information at the right time 

We do our best to communicate honestly, openly and sincerely.  This involves mutual sharing at the right time of realistic, clear and comprehensive information amongst our team, customers and partners to maintain relationships of trust.

Our mission and vision

Our Mission

At MaSTherCell we believe the best way to serve our customers is to combine scientific expertise and business and operational acumen to provide an unequalled manufacturing service in the cell therapy field. Put simply, our mission is to help our customers bring highly potent cell therapy products faster to the market. Our technology-driven, quality-minded and customer-oriented team of committed experts are dedicated to achieving that mission.·       

Our Vision

Building a customer oriented culture and a quality driven organisation that will create trust amongst our customers by ensuring access to quality products for their patients.

Our story

MaSTherCell, (Manufacturing Synergies for Therapeutic Cells) was founded in 2011 as a cell therapy dedicated Contract Development and Manufacturing Organization (CDMO). From the outset, the aim of the company was to combine academic and industry excellence to provide unparalleled quality manufacturing services.

The company was set up with investment from the founders as well as from institutional investors Sambrinvest and Sofipole and other private investors, and also with the support of the Walloon Region and its Life Sciences cluster, BioWin.

Located in just 40 minutes from Brussels, the capital of Europe, MaSTherCell's state-of-the-art facilities in theI-tech Incubator Building in Gosselies are now fully operational and received the final cGMP manufacturing authorization from the BelgianDrug Agency (AFMPS) in September 2013.

MaSTherCell's considerable expertise is based on the background of its principals who, between them, combine close to 100 years of senior managerial and scientific experience in the Life Sciences sector.

Through a reversible deal, MaSTherCell has been acquired by Orgenesis (a leader in the emerging fields of cellular therapy and re-generative medicine for the treatment of Type 1 Diabetes) in March 2015. MaSTherCell will be responsible for the development and the commercialization of Orgenesis' product and will also maintain his CDMO core business activity in an independent way.

In 2017, MaSTherCell will reach more than 100 employees with a global presence in order to crystalize its position as ultimate cell therapy manufacturing partner for leading biotech companies targeting a fast and cost effective development of their product to the market.